Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer. - Wikidata - awgldk - TriplyDB

Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer.

Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer.

http://www.wikidata.org/entity/Q40372047

about

Human VRK2 modulates apoptosis by interaction with Bcl-xL and regulation of BAX gene expression Epithelial cell dissemination and readhesion: analysis of factors contributing to metastasis formation in breast cancer Therapeutic usefulness of postoperative adjuvant chemotherapy with Tegafur-Uracil (UFT) in patients with breast cancer: focus on the results of clinical studies in Japan Phase II trial of tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancer Predictive and prognostic molecular markers for cancer medicine Supervised risk predictor of breast cancer based on intrinsic subtypes Prospective comparison of clinical and genomic multivariate predictors of response to neoadjuvant chemotherapy in breast cancer.Concordant gene expression signatures predict clinical outcomes of cancer patients undergoing systemic therapy A proof-of-principle study of epigenetic therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer.Prediction of the outcome of preoperative chemotherapy in breast cancer using DNA probes that provide information on both complete and incomplete responses Gene expression profiling of breast cancer.Optimal approach in early breast cancer: Adjuvant and neoadjuvant treatment.Challenging the roles of CD44 and lipolysis stimulated lipoprotein receptor in conveying Clostridium perfringens iota toxin cytotoxicity in breast cancer.Deconstructing the molecular portraits of breast cancer.Prognostic model for predicting overall survival in children and adolescents with rhabdomyosarcoma.Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer.Predictions of the pathological response to neoadjuvant chemotherapy in patients with primary breast cancer using a data mining technique.Pathologic response prediction to neoadjuvant chemotherapy utilizing pretreatment near-infrared imaging parameters and tumor pathologic criteria Local recurrence rates are low in high-risk neoadjuvant breast cancer in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657)An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer.Magnetic resonance metabolic profiling of breast cancer tissue obtained with core needle biopsy for predicting pathologic response to neoadjuvant chemotherapy The role of lipolysis stimulated lipoprotein receptor in breast cancer and directing breast cancer cell behavior.An interactive tool for individualized estimation of conditional survival in rectal cancer.A preoperative nomogram to predict the risk of synchronous distant metastases at diagnosis of primary breast cancer.Nomogram for predicting breast conservation after neoadjuvant chemotherapy.Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer.Pathological complete response in breast cancer patients following neoadjuvant chemotherapy at a Comprehensive Cancer Center: The natural history of an elusive prognosticator.The Computerized Table Setting Test for Detecting Unilateral Neglect.Letrozole in the neoadjuvant setting: the P024 trial.A nomogram for predicting pathological complete response in patients with human epidermal growth factor receptor 2 negative breast cancer.Clinical nomogram to predict bone-only metastasis in patients with early breast carcinoma Clinical trial update: implications and management of residual disease after neoadjuvant therapy for breast cancer High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategies.Antibacterial-coated suture in reducing surgical site infection in breast surgery: a prospective study.A risk score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancer Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas A Nomogram for Predicting the Pathological Response of Axillary Lymph Node Metastasis in Breast Cancer Patients.Radiation-induced gene signature predicts pathologic complete response to neoadjuvant chemotherapy in breast cancer patients Genomic grade index is associated with response to chemotherapy in patients with breast cancer.Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial

P2860

Q24321199-A31E2521-3C65-438F-B624-991B4460CB77 Q24606925-EF586FB8-9639-48B3-86BC-2D0ABFDF6F48 Q24633384-607895C7-C5DB-4651-890A-BBBE911B0A28 Q28240692-511EA6DC-8D04-4703-B455-80900CC3B951 Q28743108-4B88387C-D577-4AD8-98DE-5F1BBA03ED7C Q29617404-F7B07CD4-FAE2-4ADF-9B92-90544668B4F2 Q30433483-AA813081-AF2B-4504-B6DD-D12B228E7105 Q30434260-561154F9-BB77-47C0-BBA3-A22E9FDA103E Q33267359-91E047F3-60BB-4E43-90A6-8CAC809E78C2 Q33325635-29E2CF0C-31C1-4C0B-90E0-17E6F434465D Q33555497-70512241-9451-4361-8931-F473A4070513 Q33698446-1FF6691C-948C-40ED-BBF1-1FC482ABE9B3 Q33864348-A2E2AA5A-99B3-42CF-B333-85DBE1A940DC Q34154147-0BF9B79F-5972-4251-BE14-6CC3B1711526 Q34174451-AF8E8AE0-EF87-40C4-A510-0270DB3C1D63 Q34275072-8BB894AA-C510-4F15-A71F-F95A21D87E5A Q34300562-C4315BB7-F9AF-4B74-8915-4E1917984284 Q35000348-CCEF6925-DE5E-4D79-9C15-C2944C8170FF Q35000874-287E9B7C-5F0E-4B67-8AE0-E474021C101C Q35034623-B41E34C5-0DFC-433D-A337-F48AA26232DB Q35075617-361AE761-54D5-4787-8122-F9FFEF180D3F Q35122705-7D3D2E14-BB0E-4C54-AF12-D3960AC27D6E Q35165402-E40750A2-A5FF-4324-A9F7-F1BEDD177D24 Q35198325-BBDD6CE6-361D-4FD9-BC56-7C27838154C8 Q35429810-7B57EBDF-F6C6-468B-A4BB-4E6CEB2996E6 Q35609692-3581C49C-ED2C-4F45-AB3E-4FFFF52F1EC8 Q35803615-DA2BF7EB-D415-4E91-8E05-2F8DECC4508C Q35895131-328DBC46-E465-4FB2-92A3-5BAC635AD17D Q36026549-C7451653-8C54-43C1-BE99-A17D588A33CD Q36096451-DEE71F38-AAAE-4915-AD40-6279D3F4B124 Q36295018-A822C804-01A5-41F2-8D8F-7FD4E9D62841 Q36458727-1F54C410-17E6-4F57-BB76-B873EAF965C6 Q36484592-07F424F1-39BD-4C3B-8744-D5147958DAE0 Q36505782-8E4D5FA8-D061-43A3-8685-F6CABB50C6EB Q36593931-A5B88030-63BA-4223-AF35-D58DB9E99C68 Q36594068-CEEEDC80-D5EC-4E84-A046-6C8DFD17C3C3 Q37220398-849545E6-2EF6-4620-9389-94D74CF9A686 Q37244377-A5ED8C8C-428D-4847-B4C8-424CE18A18F5 Q37278382-348813EB-C8E5-45C5-94B8-F70D733B5F4D Q37347500-1B4D75AF-21CC-4121-B91B-4F932C484073

P2860

Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer.

http://www.wikidata.org/entity/Q40372047

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Nomograms to predict pathologi ...... hemotherapy for breast cancer.

@en

type

label

Nomograms to predict pathologi ...... hemotherapy for breast cancer.

@en

prefLabel

Nomograms to predict pathologi ...... hemotherapy for breast cancer.

@en

P1433

Q40372047-33734923-73DD-4297-9883-BC8130F38100

P1476

Q40372047-5340ED65-1950-4D77-89D3-DB7FA5F546A9

P2093

Q40372047-029F9B8F-33CA-465E-B798-E101E7614B4F

Q40372047-1032BA2D-F5D1-46F5-8F1A-BA0C8186BA6B

Q40372047-14AEAFE5-D542-4AEE-83FB-32F851E807C4

Q40372047-1F2D082F-67B0-41DD-99A7-793CF69DBB84

Q40372047-25201859-F887-4888-B756-26C0054F3986

Q40372047-33B1DF93-1999-4073-BF04-5854AAF6E77C

Q40372047-3E4B771B-257E-489E-973F-0CD05ACF5025

Q40372047-573B4C5C-7507-424A-BD20-5CD2CC302F99

Q40372047-5A44F3DD-D262-40DE-BE99-8A631BB52B27

Q40372047-5ED1A309-B4CA-4BC7-A05D-1FF6FDA2295B

P304

Q40372047-4FA62300-7B00-42B1-88A1-A4C9089B3676

P31

Q40372047-91124334-A849-4F00-93DC-611693CB8B95

P356

Q40372047-635D60DA-5989-4183-AAE6-46CE2D969FC8

P407

Q40372047-C4B65F9F-28B7-49D4-9C53-0C19DD904E75

P433

Q40372047-6CDF604A-9F4F-44AF-AC3F-145008B323BA

P478

Q40372047-1942542C-B5A0-41E9-8D55-0FDFA90F36C6

P50

Q40372047-0AC72E5A-D5AE-4E89-8749-98C62227B269

Q40372047-A7425AA0-EFF8-4DBD-B96D-16CBF4EE750F

Q40372047-D585B9C2-0A16-40EB-8538-ED253C353867

P577

Q40372047-DEA3E536-6EAE-4D83-9AF8-B57B2B3AF7B4

P698

Q40372047-01A66E61-0E21-4C18-B7FB-C0EE1BF0A494

P921

Q40372047-268D57AC-75FE-46C3-8C90-5BA4C65AB631

P356

JCO.2005.01.2898

P1433

Journal of Clinical Oncology

P1476

Nomograms to predict pathologi ...... hemotherapy for breast cancer.

@en

P2093

Aman U Buzdar

http://www.w3.org/2001/XMLSchema#string

Ana M Gonzalez-Angulo

http://www.w3.org/2001/XMLSchema#string

David Atallah

http://www.w3.org/2001/XMLSchema#string

Donald A Berry

http://www.w3.org/2001/XMLSchema#string

Fabrice Andre

http://www.w3.org/2001/XMLSchema#string

Gabriel N Hortobagyi

http://www.w3.org/2001/XMLSchema#string

Jean-Remi Garbay

http://www.w3.org/2001/XMLSchema#string

Kenneth R Hess

http://www.w3.org/2001/XMLSchema#string

Lajos Pusztai

http://www.w3.org/2001/XMLSchema#string

Marc Spielmann

http://www.w3.org/2001/XMLSchema#string

P304

8331-8339

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2005.01.2898

http://www.w3.org/2001/XMLSchema#string

P407

P433

33

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Suzette Delaloge

Marie-Christine Mathieu

P577

2005-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16293864

http://www.w3.org/2001/XMLSchema#string

P921